Lord, Abbett & Co
NBP

Lord, Abbett & Co’s NovaBridge Biosciences American Depositary Shares NBP Stock Holding History

Lord, Abbett & Co’s Portfolio NBP Stock Details NBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-69,355
Closed -$5.82M – 667
2021
Q2 		$5.82M Sell
69,355
-25,919
-27% -$1.71M 0.01% 601
2021
Q1 		$4.62M Buy
95,274
+25,704
+37% +$1.39M 0.01% 594
2020
Q4 		$3.28M Buy
+69,570
New +$2.74M 0.01% 608

Other funds holding NBP

HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
CC
Cederberg Capital London, United Kingdom $186M AUM 21.27% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ZAM
Zeal Asset Management Central, Hong Kong $39.4M AUM 38.83% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PAMS
Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

Lord, Abbett & Co's NBP Position: Q3 2021 in Review

Lord, Abbett & Co sold out of NovaBridge Biosciences American Depositary Shares (NBP) in Q3 2021, closing a stake of 69,355 shares — an estimated $5.82M sold.

Lord, Abbett & Co first reported a position in NBP in Q4 2020 and held it in 3 quarters. The position peaked at $5.82M in Q2 2021. 144 funds tracked by Wall St. Rank hold NBP as of Q3 2021.

  • Lord, Abbett & Co reported no remaining NovaBridge Biosciences American Depositary Shares position as of Q3 2021 after selling out during the quarter.
  • Lord, Abbett & Co sold 69,355 NovaBridge Biosciences American Depositary Shares shares in Q3 2021, an estimated $5.82M.
  • Lord, Abbett & Co first reported a position in NovaBridge Biosciences American Depositary Shares in Q4 2020 and held it in 3 quarters.
  • Lord, Abbett & Co's NovaBridge Biosciences American Depositary Shares position peaked at $5.82M in Q2 2021.
  • 144 funds tracked by Wall St. Rank held NovaBridge Biosciences American Depositary Shares as of Q3 2021.

Based on Lord, Abbett & Co's 13F filing for Q3 2021, filed 9 Nov 2021.